27 results
6-K
EX-99.1
TRIB
Trinity Biotech Plc
30 Apr 24
Statement of Assets Acquired and Liabilities Assumed
12:28pm
device and any subsequently developed sensor would be subject to regulatory oversight from the FDA and country specific regulatory authorities and would
6-K
EX-4.21
TRIB
Trinity Biotech Plc
1 Feb 24
Trinity Biotech Announces Acquisition of the CGM Assets of
11:33am
” means any Governmental Authority that is concerned with or has regulatory or supervisory oversight with respect to any Product or any Product Development
6-K
EX-99.1
TRIB
Trinity Biotech Plc
6 Sep 23
This report has been prepared in accordance with the Irish Companies Act 2014
4:04pm
this framework, the FDA issued draft guidance in October 2014 that, when finalized, would adopt a risk-based framework that would increase FDA oversight of LDTs … .
Our laboratory operated by our subsidiary Immco Diagnostics Inc. is subject to CLIA, which is administered by CMS and extends federal oversight
6-K
EX-99.3
84iq 29gkm7
15 Nov 22
Current report (foreign)
4:05pm
6-K
EX-99.1
t92jnis0 k5wia
12 Sep 22
This report has been prepared in accordance with the Irish Companies Act 2014
12:31pm
6-K
EX-99.2
0jr8rq p16a1
16 Dec 21
Trinity Biotech Announces Q3 2021 Results, the Entry Into a
7:25am
6-K
EX-99.1
evlxbas
17 Sep 21
This report has been prepared in accordance with the Irish Companies
4:36pm